Tradestie Institutional Equity Comparison Engine

BBNX vs KIDS โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-19 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

KIDS Overall Edge

KIDS Captures Institutional Edge (3โ€“0 Pillars ยท 6โ€“2 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to OrthoPediatrics Corp. Common Stock (KIDS) driven by superior Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, BBNX trades at N/M Forward P/E with -72.8% operating margin (+30.3% YoY revenue) versus KIDS at N/M Forward P/E and -8.2% operating margin (+18.6% YoY). In options structure, BBNX sits in BREAKDOWN (100th %ile IV; Dealer Gamma Walls on Pro) against KIDS sits in UNCLASSIFIED (100th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner Tie
BBNX N/M vs KIDS N/M Fwd P/E
Growth & Margin Winner KIDS
Op Margin -72.8% vs -8.2% ยท YoY +30.3% vs +18.6%
Momentum & Technical Winner KIDS
1Y -50.9% vs +98.8% ยท 52W Pos 19% vs 90%
Options & Structure Winner KIDS
BREAKDOWN (100th %ile IV) vs UNCLASSIFIED (100th %ile IV)
BBNX NASDAQ
Beta Bionics, Inc. Common Stock
Surgical & Medical Instruments & Apparatus
$13.32
-7.05% 1D
Market Cap $779.1M
1M Return -27.61%
1Y Return -50.87%
Forward P/E N/M
Unified AI Score
42.1 / 100 HOLD
Tech 33.0 Fund 55.0 Flow 69.0 Mom 60.0
KIDS NASDAQ
OrthoPediatrics Corp. Common Stock
Surgical & Medical Instruments & Apparatus
$32.51
+2.72% 1D
Market Cap $850.2M
1M Return +36.37%
1Y Return +98.84%
Forward P/E N/M
Unified AI Score
45.1 / 100 HOLD
Tech 28.0 Fund 40.0 Flow 50.0 Mom 46.3

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: BBNX -50.87% KIDS +98.84% Spread: +149.71 pp (KIDS Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
BBNX TTM Op. Margin: -72.8% KIDS TTM Op. Margin: -8.2%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on BBNX vs KIDS. Trailing 12-month operating profitability (BBNX -72.8% vs KIDS -8.2%) and valuation multiples (BBNX N/M vs KIDS N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: BBNX (2) vs KIDS (6)
Institutional Metric BBNX KIDS Criterion Row Winner
Market Capitalization Scale $779.1M $850.2M Larger Scale KIDS
Trailing P/E Ratio Valuation N/M N/M Lower Multiple Tie
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +30.3% +18.6% Higher Growth BBNX
Operating Margin (TTM) Profitability -72.8% -8.2% Higher Margin KIDS
Net Profit Margin Profitability -65.3% -12.8% Higher Margin KIDS
Return on Equity (ROE) Capital Efficiency -23.9% -9.8% Higher ROE KIDS
52-Week Range Position Momentum 19% ($9โ€“$33) 90% ($14โ€“$35) Stronger Trend KIDS
Beta / 30D Volatility Risk Regime 1.90ฮฒ ยท 107% Vol 0.81ฮฒ ยท 108% Vol Lower Realized Risk BBNX
Unified Institutional Score Composite Signal 42.1 / 100 (HOLD) 45.1 / 100 (HOLD) Higher Composite KIDS

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full BBNX vs KIDS Buy Guide
BBNX BREAKDOWN
87d in phase ยท OBV DISTRIBUTION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live BBNX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
KIDS UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 100th %ile
IV Regime Extreme (>80th %ile)
Live KIDS Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither BBNX nor KIDS registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.